J. D. Finley's most recent trade in Palisade Bio Inc was a trade of 3,227,384 shares done . Disclosure was reported to the exchange on Oct. 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2026 | 3,227,384 | 3,356,672 | - | - | - | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.49 per share. | 06 Oct 2026 | 1,411,982 | 1,944,690 | - | 1.5 | 2,103,853 | - |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Aug 2026 | 88,400 | 129,288 | - | 0 | Common Stock | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Aug 2026 | 88,400 | 88,451 | - | 0 | Common Stock | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2026 | 335,167 | 364,353 | - | - | Common Stock | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO | 06 Jul 2026 | 335,167 | 1,675,833 | - | - | Restricted Stock Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO | Sale of securities on an exchange or to another person at price $ 2.07 per share. | 06 Jul 2026 | 146,798 | 217,555 | - | 2.1 | 303,343 | Common Stock |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.70 per share. | 06 Jul 2026 | 133 | 217,688 | - | 0.7 | 93 | Common Stock |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO | 06 Jul 2026 | 133 | 0 | - | - | Series 2 Common Stock Purchase Warrant | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO | 11 Feb 2026 | 13,333 | 26,667 | - | - | Restricted Stock Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2026 | 13,333 | 31,249 | - | - | Common Stock | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2026 | 13,333 | 31,249 | - | - | - | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO | Sale of securities on an exchange or to another person at price $ 1.75 per share. | 11 Feb 2026 | 3,896 | 27,353 | - | 1.8 | 6,818 | Common Stock |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO | Sale of securities on an exchange or to another person at price $ 1.75 per share. | 11 Feb 2026 | 3,896 | 27,353 | - | 1.8 | 6,818 | - |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO | 09 Feb 2026 | 2,011,000 | 2,011,000 | - | - | Restricted Stock Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO | 06 Oct 2025 | 9,179,400 | 9,179,400 | - | - | Restricted Stock Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO | 04 Sep 2025 | 323,400 | 323,400 | - | - | Phantom Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO | 11 Feb 2025 | 47,000 | 47,000 | - | - | Stock Option (Right to Buy) | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO | 11 Feb 2025 | 40,000 | 40,000 | - | - | Restricted Stock Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,335 | 12,927 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | 28 May 2024 | 3,335 | 0 | - | - | Restricted Stock Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 2,111 | 14,079 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | 28 May 2024 | 2,111 | 0 | - | - | Restricted Stock Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 1,622 | 10,059 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | 28 May 2024 | 1,622 | 0 | - | - | Restricted Stock Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.76 per share. | 28 May 2024 | 959 | 11,968 | - | 4.8 | 4,565 | Common Stock, par value $0.01 |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.76 per share. | 28 May 2024 | 607 | 13,472 | - | 4.8 | 2,889 | Common Stock, par value $0.01 |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.76 per share. | 28 May 2024 | 467 | 9,592 | - | 4.8 | 2,223 | Common Stock, par value $0.01 |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Purchase of securities on an exchange or from another person at price $ 4.81 per share. | 24 May 2024 | 1,000 | 8,437 | - | 4.8 | 4,810 | Common Stock, par value $0.01 |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Grant, award, or other acquisition of securities at price $ 4.97 per share. | 20 May 2024 | 666 | 7,437 | - | 5.0 | 3,312 | Common Stock, par value $0.01 |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2024 | 232 | 6,688 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | 06 May 2024 | 232 | 1,622 | - | - | Restricted Stock Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2024 | 211 | 6,832 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | 06 May 2024 | 211 | 2,111 | - | - | Restricted Stock Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.46 per share. | 06 May 2024 | 67 | 6,621 | - | 8.5 | 567 | Common Stock, par value $0.01 |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.46 per share. | 06 May 2024 | 61 | 6,771 | - | 8.5 | 516 | Common Stock, par value $0.01 |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2024 | 5,558 | 96,849 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | 11 Mar 2024 | 5,558 | 50,025 | - | - | Restricted Stock Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Purchase of securities on an exchange or from another person at price $ 0.47 per share. | 06 Feb 2024 | 10,000 | 84,649 | - | 0.5 | 4,692 | Common Stock, par value $0.01 |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | 06 Feb 2024 | 3,475 | 27,800 | - | - | Restricted Stock Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 3,475 | 88,124 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | 06 Feb 2024 | 3,167 | 34,833 | - | - | Restricted Stock Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 3,167 | 91,291 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Purchase of securities on an exchange or from another person at price $ 0.56 per share. | 31 Jan 2024 | 10,000 | 74,649 | - | 0.6 | 5,590 | Common Stock, par value $0.01 |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | 03 Jan 2024 | 1,309 | 0 | - | - | Restricted Stock Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 1,309 | 64,649 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | 11 Dec 2023 | 5,559 | 55,583 | - | - | Restricted Stock Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2023 | 5,559 | 63,340 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Grant, award, or other acquisition of securities at price $ 0.51 per share. | 20 Nov 2023 | 10,000 | 57,781 | - | 0.5 | 5,100 | - |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2023 | 3,475 | 47,781 | - | 0 | - | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2023 | 1,309 | 44,703 | - | 0 | - | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.55 per share. | 03 Oct 2023 | 397 | 44,306 | - | 0.5 | 218 | - |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Purchase of securities on an exchange or from another person at price $ 0.54 per share. | 27 Sep 2023 | 15,000 | 43,394 | - | 0.5 | 8,088 | - |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Purchase of securities on an exchange or from another person at price $ 0.66 per share. | 13 Sep 2023 | 15,000 | 28,394 | - | 0.7 | 9,825 | - |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2023 | 5,558 | 15,186 | - | 0 | - | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.66 per share. | 11 Sep 2023 | 1,792 | 13,394 | - | 0.7 | 1,174 | - |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2023 | 3,475 | 11,057 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | 06 Aug 2023 | 3,475 | 34,750 | - | - | Restricted Stock Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.70 per share. | 06 Aug 2023 | 1,040 | 9,628 | - | 0.7 | 728 | Common Stock, par value $0.01 |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | 03 Jul 2023 | 1,309 | 2,618 | - | - | Restricted Stock Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2023 | 1,309 | 7,582 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.76 per share. | 03 Jul 2023 | 389 | 7,193 | - | 1.8 | 686 | Common Stock, par value $0.01 |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2023 | 3,475 | 7,323 | - | 0 | - | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.54 per share. | 12 Jun 2023 | 1,050 | 6,273 | - | 1.5 | 1,619 | - |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | 11 Jun 2023 | 148,500 | 148,500 | - | - | Common Stock Options | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | 11 Jun 2023 | 66,700 | 66,700 | - | - | Restricted Stock Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | 03 Apr 2023 | 1,309 | 3,927 | - | - | Restricted Stock Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 1,309 | 4,283 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.01 per share. | 03 Apr 2023 | 435 | 3,848 | - | 2.0 | 874 | Common Stock, par value $0.01 |
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | 06 Feb 2023 | 57,200 | 57,200 | - | - | Common Stock Purchase Option | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | 06 Feb 2023 | 41,700 | 41,700 | - | - | Restricted Stock Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Director, CEO, CFO, Director | 06 Feb 2023 | 32,500 | 32,500 | - | - | Restricted Performance Stock Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Chief Executive Officer | 03 Jan 2023 | 5,236 | 5,236 | - | - | Restricted Stock Units | ||
| Palisade Bio Inc | Mr. J. D. Finley | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.16 per share. | 23 Aug 2022 | 7,350 | 129,246 | - | 0.2 | 1,176 | Common Stock, par value $0.01 |
| Palisade Bio Inc | Mr. J. D. Finley | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.25 per share. | 16 Aug 2022 | 100,000 | 121,896 | - | 0.3 | 25,000 | Common Stock, par value $0.01 |
| Palisade Bio Inc | Mr. J. D. Finley | Chief Financial Officer | 16 Aug 2022 | 100,000 | 100,000 | - | - | Series 1 Common Stock Purchase Warrant | ||
| Palisade Bio Inc | Mr. J. D. Finley | Chief Financial Officer | 16 Aug 2022 | 100,000 | 100,000 | - | - | Series 2 Common Stock Purchase Warrant | ||
| Palisade Bio Inc | Mr. J. D. Finley | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 29 Apr 2022 | 12,545 | 38,867 | - | 0 | Common Stock | |
| Palisade Bio Inc | Mr. J. D. Finley | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.09 per share. | 24 Mar 2022 | 7,500 | 21,896 | - | 1.1 | 8,174 | Common Stock |
| Palisade Bio Inc | Mr. J. D. Finley | Chief Financial Officer | 17 Feb 2022 | 64,800 | 64,800 | - | - | Stock Option (right to buy) |